Alpern JD, Kesselheim AS - Journal of General Internal Medicine
- Research Publications
- Regulation and Clinical Evidence
Summary:
Among 23 physician members who voted on the ACIP between 2023 and 2024, only 5 (22%) received industry payments relevant to a vote during their tenure, of which 93% were research payments rather than personal compensation. These findings refute claims that the former ACIP was plagued with industry conflicts of interest, and the authors argue that future policy decisions impacting the committee should be data-driven.
VIEW SOURCE
Recent Work from PORTAL
How Congress Can Fix Expert Advisory Committees
Daval CJR, Kesselheim AS - STAT
- Commentary & Opinion
- Regulation and Clinical Evidence
International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway
Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy
- Research Publications
- Price, Value, and Access
- Regulation and Clinical Evidence
Politics and the Patient Encounter, in Dire Times
Avorn J - MedPage Today
- Commentary & Opinion
- Regulation and Clinical Evidence
Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115
©2026 Program On Regulation, Therapeutics, And Law (PORTAL). All rights reserved.